| 1 |
Discovery research for a first-in-class lead live-microbial gene therapy to control gut-GVHD |
| Other-Bio. |
GVHD (Graft-versus-Hose Disease) |
Regulatory T cells |
Lead |
Liveome Inc. |
RS-2024-00460623 |
|
| 2 |
Development of BFD1R, an immunomodulatory Live Biotherapeutic Products(LBP) for rheumatoid arthritis |
| Other-Bio. |
Rheumatoid Arthritis |
Gut (Gut.joint axis |
Preclinical |
BIFIDO Co., Ltd |
RS-2023-00258617 |
|
| 3 |
Non-clinical study of IBD using Live Microbial Gene Therapy based on recombinant microbial Toolbox |
| Other-Bio. |
Ulcerative colitis |
VIP |
Preclinical |
Liveome Inc. |
RS-2023-00217138 |
|
| 4 |
Therapeutic exosome development in Inflammatory Bowel Disease (IBD)
with CARD9/TRIM62 Protein-Protein Interaction (PPI) inhibition activity |
| Other-Bio. |
Inflammatory Bowel Disease |
CARD9, TRIM62 |
Hit |
ILIAS Biologics Inc. |
HN22C0582 |
|